STJ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, St Jude Medical's enterprise value is $22,912 Mil. St Jude Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 was $5,956 Mil. Therefore, St Jude Medical's EV-to-Revenue for today is 3.85.
The historical rank and industry rank for St Jude Medical's EV-to-Revenue or its related term are showing as below:
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-04-26), St Jude Medical's stock price is $80.82. St Jude Medical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2016 was $20.70. Therefore, St Jude Medical's PS Ratio for today is 3.90.
The historical data trend for St Jude Medical's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
St Jude Medical Annual Data | |||||||||||||||||||||
Trend | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | |||||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 2.28 | 2.28 | 3.69 | 3.74 | 4.18 |
St Jude Medical Quarterly Data | ||||||||||||||||||||
Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | |
EV-to-Revenue | Get a 7-Day Free Trial | 3.68 | 4.18 | 3.78 | 4.81 | 4.73 |
For the Medical Devices subindustry, St Jude Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, St Jude Medical's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where St Jude Medical's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
St Jude Medical's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 22911.600 | / | 5956 | |
= | 3.85 |
St Jude Medical's current Enterprise Value is $22,912 Mil.
St Jude Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,956 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
St Jude Medical (NYSE:STJ) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
St Jude Medical's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 80.82 | / | 20.697 | |
= | 3.90 |
St Jude Medical's share price for today is $80.82.
St Jude Medical's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $20.70.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of St Jude Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Jeff Fecho | officer: VP, Global Quality | ONE ST. JUDE MEDICAL DRIVE ST. PAUL MN 55117 |
Philip Ebeling | officer: VP, Chief Technology Officer | INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416 |
Donald Zurbay | officer: VP Finance and CFO | C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
Michael A Rocca | director | C/O LIGAND PHARMACEUTICALS INCORPORATED, 10275 SCIENCE CENTER DRIVE, SAN DIEGO CA 92121 |
Barbara B Hill | director | |
Wendy L Yarno | director | |
Stuart Essig | director | 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
John C Heinmiller | officer: Executive Vice President | ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
John W Brown | director | STRYKER CORP, 2725 FAIRFIELD ROAD, KALAMAZOO MI 49002 |
David C Dvorak | director | C/O ZIMMER INC, PO BOX 708, WARSAW IN 46580 |
Michael T Rousseau | director, officer: Director, President and CEO | ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
Eric S Fain | officer: Group President | ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN |
Daniel J Starks | director | ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117 |
Joel Becker | officer: President, Americas | ONE ST. JUDE MEDICAL DRIVE, ST. PAUL MN 55418 |
Rohan Hoare | officer: President - NMD | 100 CYBERONICS BLVD, HOUSTON TX 77058 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 02-04-2010
By gurufocus • 08-12-2009
By gurufocus 10qk • 08-11-2010
By GuruFocus Research GuruFocus Editor • 11-06-2009
By Holly LaFon Holly LaFon • 10-31-2016
By GuruFocus Research GuruFocus Editor • 05-14-2010
By GuruFocus Research GuruFocus Editor • 12-07-2009
By gurufocus • 08-03-2006
By Victor Selva Victor Selva • 04-30-2014
By GuruFocus Research GuruFocus Editor • 09-14-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.